During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research published in The Lancet medical journal. The drug lenacapavir passed a critical ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

Millions of people worldwide are likely to lose access to anti HIV drugs, and thousands more people could die, after the US ...

A South African Medical Research Council (SAMRC) study has revealed that HIV remains one of the leading causes of death in ...

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

COLUMBIA, S.C. (WOLO)– Tuesday, March 11, is National Women’s and Girl’s HIV Aids Awareness Day. In recognition the Department of Public Health says it will offer free testing at its locations across ...

Kenya has the seventh-largest number of people living with HIV in the world, at around 1.4 million, according to World Health ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...